Silylated cyclic phosphonamides

US2016289247A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016289247-A1
Application numberUS-201415038322-A
CountryUS
Kind codeA1
Filing dateNov 21, 2014
Priority dateNov 26, 2013
Publication dateOct 6, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to silylated cyclic phosphonamides of the general formula (1) in which R 1 represents an unsubstituted or fluoro-substituted alkyl group with 1-20 carbon atoms, R 2 , R 3 each represent an unsubstituted or fluoro-substituted alkyl or alkyl group with 1-20 carbon atoms or a siloxy group with 1-20 silicon atoms, wherein two or three of the groups R 1 , R 2 , R 3 can be connected to each other, R4 represents an unsubstituted or fluoro-substituted alkyl group with 1-20 carbon atoms, and n represents the values 1 or 2. The invention also relates to a method for producing the phosophonamides of the general formula (1), to diamines used during the production of the phosphonamides, to an electrolyte which contains the phosphonamides of the general formula (1), and to a lithium-ion battery which comprises a cathode, an anode, a separator, and the electrolyte.

First claim

Opening claim text (preview).

1 . A silylated cyclic phosphonamide of the general formula 1 where R 1 is an unsubstituted or fluorine-substituted alkyl radical having 1-20 carbon atoms, R 2 , R 3 are each an unsubstituted or fluorine-substituted alkyl or alkoxy radical having 1-20 carbon atoms or a siloxy radical having 1-20 silicon atoms, where two or three of the radicals R 1 , R 2 , R 3 can be joined to one another, R 4 is an unsubstituted or fluorine-substituted alkyl radical having 1-20 carbon atoms and n is 1 or 2. 2 . The silylated cyclic phosphonamide as claimed in claim 1 , wherein R 1 and R 4 are members independently selected from the group consisting of methyl, ethyl, n-propyl and isopropyl radicals. 3 . The silylated cyclic phosphonamide as claimed in claim 1 , wherein R 2 and R 3 are members independently selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, methoxy and ethoxy radicals. 4 . A process for preparing silylated cyclic phosphonamides of the general formula 1 wherein diamines of the general formula 2 R 1 R 2 R 3 Si—CH 2 —NH—CH 2 —(CH 2 ) n —NH—CH 2 —SiR 1 R 2 R 3   (2) are reacted with a phosphonic dihalide of the general formula 3 R 4 POX 2   (3), where X is fluorine, chloride or bromine, R 1 is an unsubstituted or fluorine-substituted alkyl radical having 1-20 carbon atoms, R 2 , R 3 are each an unsubstituted or fluorine-substituted alkyl or alkoxy radical having 1-20 carbon atoms or a siloxy radical having 1-20 silicon atoms, where two or three of the radicals R 1 , R 2 , R 3 can be joined to one another, R 4 is an unsubstituted or fluorine-substituted alkyl radical having 1-20 carbon atoms and n is 1 or 2. 5 . The process as claimed in claim 4 , wherein X is chlorine. 6 . An electrolyte containing aprotic solvent, lithium-containing electrolyte salt and the silylated cyclic phosphonamide of the general formula 1 as claimed in claim 1 . 7 . The electrolyte as claimed in claim 6 , wherein the aprotic solvent is a member selected from the group consisting of organic carbonates, cyclic esters, linear esters, cyclic ethers, linear ethers, ketones, lactones, sulfolanes, dimethyl sulfoxide, formamide, dimethylformamide, 3-methyl-1,3-oxazolidin-2-one and mixtures of these solvents. 8 . The electrolyte as claimed in claim 6 , wherein the lithium-containing electrolyte salt is a member selected from the group consisting of LiPF 6 , LiBF 4 , LiClO 4 , LiAsF 6 , LiSO 3 C x F 2x+1 , (LiB(C 2 O 4 ) 2 , LiBF 2 (C 2 O 4 )), LiN(SO 2 C x F 2x+1 ) 2 and LiC(SO 2 CxF 2x+1 ) 3 , where x is an integer from 0 to 8, and mixtures thereof. 9 . The electrolyte as claimed in claim 6 , containing 1-10% by weight of the phosphonamide of the general formula 1. 10 . A lithium ion battery comprising a cathode, an anode, a separator and the electrolyte as claimed in claim 6 . 11 . (canceled) 12 . The silylated cyclic phosphonamide as claimed in claim 2 , wherein R 2 and R 3 are members independently selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, methoxy and ethoxy radicals. 13 . The electrolyte as claimed in claim 7 , wherein the lithium-containing electrolyte salt is a member selected from the group consisting of LiPF 6 , LiBF 4 , LiClO 4 , LiAsF 6 , LiSO 3 C x F 2x+1 , (LiB(C 2 O 4 ) 2 , LiBF 2 (C 2 O 4 )), LiN(SO 2 C x F 2x+1 ) 2 and LiC(SO 2 CxF 2x+1 ) 3 , where x is an integer from 0 to 8, and mixtures thereof. 14 . The electrolyte as claimed in claim 13 , containing 0.1-10% by weight of the phosphonamide of the general formula 1. 15 . A lithium ion battery comprising a cathode, an anode, a separator and the electrolyte as claimed in claim 14 .

Assignees

Inventors

Classifications

  • Cyclic amide derivatives of acids of phosphorus, in which two nitrogen atoms belong to the ring · CPC title

  • C07F7/0803Primary

    Compounds with Si-C or Si-Si linkages · CPC title

  • Rocking-chair batteries, i.e. batteries with lithium insertion or intercalation in both electrodes; Lithium-ion batteries · CPC title

  • characterised by the solutes · CPC title

  • C07F7/082Primary

    Chemistry & Metallurgy · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016289247A1 cover?
The invention relates to silylated cyclic phosphonamides of the general formula (1) in which R 1 represents an unsubstituted or fluoro-substituted alkyl group with 1-20 carbon atoms, R 2 , R 3 each represent an unsubstituted or fluoro-substituted alkyl or alkyl group with 1-20 carbon atoms or a siloxy group with 1-20 silicon atoms, wherein two or three of the groups R 1 , R 2 , R 3 can be co…
Who is the assignee on this patent?
Wacker Chemie Ag
What technology area does this patent fall under?
Primary CPC classification C07F9/65848. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Oct 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).